|
시장보고서
상품코드
2089117
예방 의료 기술 및 서비스 시장 : 서비스별, 제공 형태별, 기술 유형별, 최종사용자별, 용도별 - 세계 예측(2026-2032년)Preventive Healthcare Technologies & Services Market by Service, Delivery Mode, Technology Type, End User, Application - Global Forecast 2026-2032 |
||||||
360iResearch
예방 의료 기술 및 서비스 시장은 2032년까지 CAGR 11.49%를 기록하며 5,730억 달러 규모로 확대될 것으로 예측됩니다.
| 주요 시장 통계 | |
|---|---|
| 기준 연도 2025년 | 2,674억 7,000만 달러 |
| 추정 연도 2026년 | 2,966억 5,000만 달러 |
| 예측 연도 2032년 | 5,730억 달러 |
| CAGR(%) | 11.49% |
소개
예방 의료 기술 및 서비스는 일회성 선별 검사 프로그램에서 데이터를 활용한 지속적인 건강 위험 관리로 전환되고 있습니다. 세계보건기구(WHO) 보고서에 따르면, 이러한 수요를 뒷받침하고 있는 것은 전 세계 전체 사망자의 약 74%를 차지하는 비전염성 질환이 전 세계에 미치는 부담과, 조기 발견, 예방 접종, 약물 복용 준수, 생활 습관 개선에 대한 필요성을 높이는 고령화 사회입니다.
예방 의료 분야의 획기적인 변화
예방 의료 분야는 소비자용 헬스케어 기기, 가치 기반 의료, 분산형 진단, 그리고 집단 건강 분석의 융합을 통해 재편되고 있습니다. 예방 서비스는 더 이상 연 1회의 검진에 그치지 않고, 지속적인 생체 측정 모니터링, 재택 검사, 원격의료를 통한 분류, 자동 알림, 백신 접종 홍보 활동, 그리고 맞춤형 코칭 등이 점점 더 많이 도입되고 있습니다.
인공지능(AI)의 누적적 영향
인공지능(AI)은 사후 대응형 케어에서 예측적 예방으로의 전환을 가속화하고 있습니다. AI 모델은 심혈관질환, 당뇨병, 암 검진 대상 적격성, 복약 순응도, 낙상, 허약, 그리고 예방 가능한 응급실 내원 등에 대한 위험도 평가를 지원하고 있습니다. 컴퓨터 비전은 방사선과, 피부과, 병리학, 안과 등 규제 대상인 진단 워크플로우에서 이미 활용되고 있으며, 이러한 분야에서는 조기 발견이 환자의 예후를 크게 개선할 가능성이 있습니다.
주요 지역별 인사이트
아시아태평양은 예방 의료 기술 분야에서 가장 활기찬 지역 중 하나입니다. 이는 대규모 인구, 만성 질환 유병률의 증가, 그리고 중국, 인도, 일본, 한국, 싱가포르, 호주에서 진행되고 있는 정부 주도의 디지털 헬스 이니셔티브에 힘입은 것입니다. 일본과 한국에서 고령화가 진행됨에 따라, 낙상 예방, 원격 모니터링, 치매 위험 관리, 조기 발견 서비스에 대한 수요가 증가하고 있습니다. 한편, 인도와 동남아시아 국가들에서는 디지털 신분증, 1차 의료 서비스 이용, 백신 접종 기록, 지역 밀착형 선별 검사의 확대가 추진되고 있습니다.
주요 그룹별 인사이트
아세안(ASEAN) 국가들에서는 디지털 헬스 플랫폼의 활용, 1차 의료의 현대화, 보편적 의료 보장 확대, 감염병 감시를 위한 국경을 초월한 협력을 통해 예방 의료가 추진되고 있습니다. 싱가포르의 기술을 활용한 돌봄 모델은 종종 해당 지역의 벤치마크 역할을 하고 있는 반면, 인도네시아, 태국, 베트남, 말레이시아, 필리핀에서는 모바일 헬스, 예방접종 프로그램, 지역사회 내 선별 검사, 디지털 공중보건 도구를 통해 의료 접근성이 확대되고 있습니다.
주요 국가에 대한 인사이트
미국은 보험사의 혁신, 고용주 주도의 웰니스 프로그램, 디지털 헬스의 높은 보급률, 규제된 소프트웨어 도입 절차, 그리고 보험 적용 정책에서 예방 서비스 권고 사항의 광범위한 활용을 통해 예방 의료 기술 분야에서 계속해서 선도적인 입지를 유지하고 있습니다. 캐나다는 공적 의료 제도, 예방접종, 암 검진 및 1차 진료의 개편을 통해 공평한 예방 대책을 중시하고 있습니다. 한편, 멕시코와 브라질은 공공 및 민간 1차 의료 네트워크를 활용하여 당뇨병, 비만, 고혈압, 심혈관질환 및 모자 보건 분야의 우선 과제를 해결해 나가고 있습니다.
업계 리더를 위한 실천적인 제안
업계 리더들은 위험, 비용, 검진 미이행, 질환 진행 또는 치료의 공백 측면에서 측정 가능한 감소 효과를 입증한, 임상적으로 검증된 솔루션을 우선적으로 고려해야 합니다. 제품은 전자 진료 기록, 보험사의 워크플로우, 약국 시스템, 검사 기관 네트워크, 연결 기기, 공중보건 등록 시스템과 통합되어, 단순한 웰니스 도구에서 통합된 예방 의료 인프라로 전환되어야 합니다.
조사 방법
본 요약본은 세계보건기구(WHO), 경제협력개발기구(OECD), 세계은행, 각국의 보건 기관, 규제 당국, 보험사의 정책 문서, 디지털 헬스 규제, 그리고 동료 심사를 거친 공중보건 문헌 등, 일반에 공개되어 빈번히 인용되는 정보원을 활용한 2차 조사 및 분석적 연구 접근법에 기초하여 작성되었습니다.
결론
예방 의료 기술과 서비스는 지속가능한 의료 시스템의 미래를 위해 필수적인 요소로 자리 잡고 있습니다. 임상적 근거, 연결된 데이터, AI를 활용한 위험 예측, 안전한 상호 운용성, 그리고 이용하기 쉬운 서비스 제공이 융합되는 분야에서 가장 큰 기회가 창출되고 있습니다.
자주 묻는 질문
목차
제1장 서문
제2장 조사 방법
제3장 주요 요약
제4장 시장 개요
제5장 시장 인사이트
제6장 AI의 누적 영향, 2026년
제7장 예방 의료 기술 및 서비스 시장 : 서비스별
제8장 예방 의료 기술 및 서비스 시장 : 배포 방식별
제9장 예방 의료 기술 및 서비스 시장 : 기술 유형별
제10장 예방 의료 기술 및 서비스 시장 : 최종사용자별
제11장 예방 의료 기술 및 서비스 시장 : 용도별
제12장 예방 의료 기술 및 서비스 시장 : 지역별
제13장 예방 의료 기술 및 서비스 시장 : 그룹별
제14장 예방 의료 기술 및 서비스 시장 : 국가별
제15장 경쟁 구도
제16장 기업 개요
KSM 26.07.21The Preventive Healthcare Technologies & Services Market is projected to grow by USD 573.00 billion at a CAGR of 11.49% by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 267.47 billion |
| Estimated Year [2026] | USD 296.65 billion |
| Forecast Year [2032] | USD 573.00 billion |
| CAGR (%) | 11.49% |
Introduction
Preventive healthcare technologies and services are moving from episodic screening programs to continuous, data-enabled health risk management. Demand is supported by the global burden of noncommunicable diseases, which the World Health Organization reports account for roughly 74% of all deaths worldwide, and by aging populations that increase the need for earlier detection, vaccination, medication adherence, and lifestyle intervention.
The sector is increasingly defined by connected diagnostics, wearable devices, remote patient monitoring, digital therapeutics, genomic screening, employer wellness platforms, immunization management, and risk-stratified primary care. Health systems, payers, employers, and public agencies are prioritizing prevention because it can reduce avoidable hospitalizations, improve quality-adjusted outcomes, and help manage rising healthcare expenditure documented across OECD and World Bank datasets.
Transformative Shifts in the Preventive Healthcare Landscape
The preventive healthcare landscape is being reshaped by the convergence of consumer health devices, value-based care, decentralized diagnostics, and population health analytics. Preventive services are no longer limited to annual visits; they increasingly include continuous biometric monitoring, home testing, telehealth triage, automated reminders, vaccination outreach, and personalized coaching.
Regulatory and reimbursement models are also evolving. In the United States, Medicare and commercial payers cover multiple preventive services without cost sharing under defined criteria, while the European Union is advancing digital health data interoperability through the European Health Data Space. Across Asia-Pacific, national digital health infrastructure programs are expanding access to vaccination records, screening pathways, chronic disease prevention, and digitally enabled primary care services.
Cumulative Impact of Artificial Intelligence
Artificial intelligence is accelerating the shift from reactive care to predictive prevention. AI models support risk scoring for cardiovascular disease, diabetes, cancer screening eligibility, medication nonadherence, falls, frailty, and avoidable emergency utilization. Computer vision is already used in regulated diagnostic workflows, including radiology, dermatology, pathology, and ophthalmology, where early detection can materially change patient outcomes.
The cumulative impact is strongest when AI is combined with clinically governed data, evidence-based protocols, transparent model validation, and human oversight. Adoption remains constrained by bias, explainability, cybersecurity, data quality, and medical liability concerns, prompting regulators such as the U.S. FDA and the European Union to increase scrutiny of software as a medical device and high-risk AI systems.
Key Regional Insights
Asia-Pacific is one of the most dynamic regions for preventive healthcare technologies, supported by large populations, rising chronic disease prevalence, and government-backed digital health initiatives in China, India, Japan, South Korea, Singapore, and Australia. Aging demographics in Japan and South Korea strengthen demand for fall prevention, remote monitoring, dementia risk management, and early detection services, while India and Southeast Asian economies are scaling digital identity, primary care access, vaccination records, and community-based screening.
North America leads in commercial digital health adoption, employer wellness, genomics, reimbursement-linked preventive care, and regulated digital medicine, with the United States providing scale and Canada emphasizing primary care access, public health equity, and population-level screening. Latin America is expanding prevention through public and private primary care networks, mobile-first access, diabetes and obesity management, and vaccination initiatives, with Brazil and Mexico playing central roles in chronic disease prevention. Europe benefits from national screening programs, strong data protection rules, interoperable health data strategies, and coordinated public health policies, particularly across cancer screening, immunization, cardiovascular risk management, and healthy aging.
The Middle East is investing in preventive care as part of healthcare transformation agendas, particularly in GCC states that are targeting obesity, diabetes, cardiovascular disease, and longevity through digital health platforms, national health records, and lifestyle medicine. Africa is leveraging mobile health, community health workers, vaccination programs, maternal and child health initiatives, and infectious disease surveillance to extend preventive services, although broadband access, workforce shortages, diagnostic infrastructure, and financing constraints continue to shape adoption.
Key Group Insights
ASEAN markets are advancing preventive healthcare through digital health platforms, primary care modernization, universal coverage expansion, and cross-border collaboration on infectious disease surveillance. Singapore's technology-enabled care model often acts as a regional benchmark, while Indonesia, Thailand, Vietnam, Malaysia, and the Philippines are expanding access through mobile health, immunization programs, community screening, and digital public health tools.
The GCC is prioritizing prevention to address obesity, diabetes, cardiovascular risk, cancer screening, and healthy aging, supported by national health transformation programs, connected care infrastructure, and growing investment in population health analytics. The European Union is emphasizing interoperability, cancer screening, vaccination, secure data sharing, and health technology regulation through policies such as the European Health Data Space and medical device rules. BRICS countries provide scale for population health innovation across China, India, Brazil, Russia, and South Africa, but adoption varies by infrastructure, reimbursement maturity, workforce capacity, and digital inclusion.
G7 markets lead in clinical standards, AI governance, advanced diagnostics, genomics, reimbursement design, and investment capacity, making them important reference points for evidence-based preventive healthcare technologies. NATO members increasingly view preventive health, biosecurity, pandemic preparedness, vaccination readiness, workforce resilience, and secure health data infrastructure as strategic priorities that connect public health with national security planning.
Key Country Insights
The United States remains a leading environment for preventive healthcare technologies due to payer innovation, employer-sponsored wellness, strong digital health adoption, regulated software pathways, and extensive use of preventive service recommendations in coverage policy. Canada emphasizes equitable prevention through public healthcare systems, vaccination, cancer screening, and primary care renewal, while Mexico and Brazil are using public and private primary care networks to address diabetes, obesity, hypertension, cardiovascular disease, and maternal and child health priorities.
In Europe, the United Kingdom, Germany, France, Italy, and Spain support preventive care through national health systems, cancer screening, vaccination programs, electronic health records, digital health reimbursement reforms, and chronic disease management initiatives. Germany's digital health reimbursement pathways, the United Kingdom's population health analytics, France's prevention planning, and Italy's and Spain's regional care models strengthen adoption, while Russia continues to focus on public health monitoring, infectious disease control, and chronic disease prevention.
China is scaling prevention through Healthy China 2030, hospital digitalization, public health surveillance, chronic disease management, and consumer health platforms. India's Ayushman Bharat Digital Mission, Health and Wellness Centres, and primary care expansion support screening access at scale for hypertension, diabetes, cancer, maternal health, and immunization. Japan, Australia, and South Korea are strong adopters of aging-related prevention, connected devices, remote monitoring, health checkup programs, and digital care coordination, reflecting their emphasis on longevity, early diagnosis, and health system efficiency.
Actionable Recommendations for Industry Leaders
Industry leaders should prioritize clinically validated solutions that demonstrate measurable reductions in risk, cost, missed screenings, disease progression, or care gaps. Products must integrate with electronic health records, payer workflows, pharmacy systems, laboratory networks, connected devices, and public health registries to move from standalone wellness tools to embedded preventive care infrastructure.
Investment should focus on evidence generation, privacy-by-design architecture, cybersecurity, inclusive datasets, accessibility, and reimbursement alignment. Organizations that partner with providers, employers, governments, and insurers can scale faster by tying preventive healthcare technologies to recognized quality measures, screening guidelines, vaccination targets, chronic disease management objectives, and health equity goals.
Research Methodology
This executive summary is developed using a secondary and analytical research approach that draws on publicly available and regularly cited sources, including the World Health Organization, OECD, World Bank, national health agencies, regulatory bodies, payer policy documents, digital health regulations, and peer-reviewed public health literature.
The methodology emphasizes triangulation across epidemiological burden, demographic trends, reimbursement structures, digital health regulation, preventive care guidelines, interoperability initiatives, and technology adoption indicators. Insights are interpreted through market relevance, clinical validity, regional policy maturity, health equity implications, data governance, and scalability of preventive healthcare technologies and services.
Conclusion
Preventive healthcare technologies and services are becoming essential to the future of sustainable health systems. The strongest opportunities are emerging where clinical evidence, connected data, AI-enabled risk prediction, secure interoperability, and accessible service delivery converge.
Organizations that can prove outcomes, protect patient trust, and integrate prevention into routine care will be best positioned to lead. As chronic disease burden, aging populations, infectious disease preparedness needs, and healthcare cost pressures intensify, prevention is shifting from a public health aspiration to a strategic operating model for healthcare systems worldwide.
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Definition
- 1.3. Market Segmentation & Coverage
- 1.4. Years Considered for the Study
- 1.5. Currency Considered for the Study
- 1.6. Language Considered for the Study
- 1.7. Key Stakeholders
2. Research Methodology
- 2.1. Introduction
- 2.2. Research Design
- 2.2.1. Primary Research
- 2.2.2. Secondary Research
- 2.3. Research Framework
- 2.3.1. Qualitative Analysis
- 2.3.2. Quantitative Analysis
- 2.4. Market Size Estimation
- 2.4.1. Top-Down Approach
- 2.4.2. Bottom-Up Approach
- 2.5. Data Triangulation
- 2.6. Research Outcomes
- 2.7. Research Assumptions
- 2.8. Research Limitations
3. Executive Summary
- 3.1. Introduction
- 3.2. CXO Perspective
- 3.3. Market Size & Growth Trends
- 3.4. Market Share Analysis, 2025
- 3.5. FPNV Positioning Matrix, 2025
- 3.6. New Revenue Opportunities
- 3.7. Next-Generation Business Models
- 3.8. Industry Roadmap
4. Market Overview
- 4.1. Introduction
- 4.2. Industry Ecosystem & Value Chain Analysis
- 4.2.1. Supply-Side Analysis
- 4.2.2. Demand-Side Analysis
- 4.2.3. Stakeholder Analysis
- 4.3. Market Dynamics
- 4.3.1. Key Drivers
- 4.3.2. Key Restraints
- 4.3.3. Key Opportunities
- 4.3.4. Key Challenges
- 4.4. Porter's Five Forces Analysis
- 4.5. PESTLE Analysis
- 4.6. Market Outlook
- 4.6.1. Near-Term Market Outlook (0-2 Years)
- 4.6.2. Medium-Term Market Outlook (3-5 Years)
- 4.6.3. Long-Term Market Outlook (5-10 Years)
- 4.7. Go-to-Market Strategy
5. Market Insights
- 5.1. Consumer Insights & End-User Perspective
- 5.2. Consumer Experience Benchmarking
- 5.3. Opportunity Mapping
- 5.4. Distribution Channel Analysis
- 5.5. Pricing Trend Analysis
- 5.6. Regulatory Compliance & Standards Framework
- 5.7. ESG & Sustainability Analysis
- 5.8. Disruption & Risk Scenarios
- 5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Preventive Healthcare Technologies & Services Market, by Service
- 7.1. Genetic Testing Services
- 7.1.1. Carrier Screening
- 7.1.2. Hereditary Cancer Testing
- 7.1.3. Pharmacogenomic Testing
- 7.2. Lifestyle Management
- 7.2.1. Fitness Coaching
- 7.2.2. Nutritional Counseling
- 7.2.3. Stress Management
- 7.3. Predictive Analytics
- 7.3.1. AI-Based Predictive Models
- 7.3.2. Risk Assessment Tools
- 7.4. Preventive Screening
- 7.4.1. Cancer Screening
- 7.4.2. Cardiovascular Screening
- 7.4.3. Diabetes Screening
- 7.4.4. Osteoporosis Screening
- 7.5. Vaccination Services
- 7.5.1. Seasonal Vaccination
- 7.5.2. Travel Vaccination
- 7.5.3. Workplace Vaccination
8. Preventive Healthcare Technologies & Services Market, by Delivery Mode
- 8.1. Home-Based
- 8.1.1. Home Visits
- 8.1.2. Self-Administered
- 8.2. In-Person
- 8.2.1. Clinic-Based
- 8.2.2. Hospital-Based
- 8.2.3. Pharmacy-Based
- 8.3. Mobile Clinics
- 8.3.1. Bus Clinics
- 8.3.2. Pop-Up Clinics
- 8.4. Virtual
- 8.4.1. App-Based
- 8.4.2. Remote Monitoring
- 8.4.3. Teleconsultation
9. Preventive Healthcare Technologies & Services Market, by Technology Type
- 9.1. Early Detection And Screening Technologies
- 9.2. Chronic Disease Management Technologies
- 9.3. Vaccination Technologies
- 9.4. Digital Health Solutions
- 9.5. Wearable Technologies
10. Preventive Healthcare Technologies & Services Market, by End User
- 10.1. Ambulatory Care Centers
- 10.1.1. Clinics
- 10.1.2. Diagnostic Centers
- 10.2. Corporate Wellness Providers
- 10.2.1. On-Site Programs
- 10.2.2. Virtual Programs
- 10.3. Home Care Settings
- 10.3.1. Remote Monitoring At Home
- 10.3.2. Self-Administered
- 10.4. Hospitals
- 10.4.1. Primary Hospitals
- 10.4.2. Specialty Hospitals
- 10.5. Individuals
- 10.5.1. Direct-To-Consumer Products
- 10.5.2. Self-Service Apps
11. Preventive Healthcare Technologies & Services Market, by Application
- 11.1. Cardiovascular Disease Prevention
- 11.1.1. Cholesterol Monitoring
- 11.1.2. Hypertension Management
- 11.1.3. Lifestyle Intervention
- 11.2. Diabetes Prevention
- 11.2.1. Blood Glucose Monitoring
- 11.2.2. Lifestyle Coaching
- 11.3. Infectious Disease Prevention
- 11.3.1. Immunization
- 11.3.2. Prophylactic Treatments
- 11.4. Oncology Screening
- 11.4.1. Breast Cancer Screening
- 11.4.2. Colorectal Cancer Screening
- 11.4.3. Lung Cancer Screening
12. Preventive Healthcare Technologies & Services Market, by Region
- 12.1. Asia-Pacific
- 12.2. North America
- 12.3. Latin America
- 12.4. Europe
- 12.5. Middle East
- 12.6. Africa
13. Preventive Healthcare Technologies & Services Market, by Group
- 13.1. ASEAN
- 13.2. GCC
- 13.3. European Union
- 13.4. BRICS
- 13.5. G7
- 13.6. NATO
14. Preventive Healthcare Technologies & Services Market, by Country
- 14.1. United States
- 14.2. Canada
- 14.3. Mexico
- 14.4. Brazil
- 14.5. United Kingdom
- 14.6. Germany
- 14.7. France
- 14.8. Russia
- 14.9. Italy
- 14.10. Spain
- 14.11. China
- 14.12. India
- 14.13. Japan
- 14.14. Australia
- 14.15. South Korea
15. Competitive Landscape
- 15.1. Market Concentration Analysis, 2025
- 15.1.1. Concentration Ratio (CR)
- 15.1.2. Herfindahl Hirschman Index (HHI)
- 15.2. Recent Developments & Impact Analysis, 2025
- 15.3. Product Portfolio Analysis, 2025
- 15.4. Benchmarking Analysis, 2025
16. Company Profiles
- 16.1. Abbott Laboratories
- 16.2. Accenture PLC
- 16.3. AliveCor Inc
- 16.4. Alphabet Inc
- 16.5. Apple Inc
- 16.6. CitiusTech Inc
- 16.7. Cognizant Technology Solutions Corporation
- 16.8. Dexcom Inc
- 16.9. Garmin Ltd
- 16.10. General Electric HealthCare Technologies Inc
- 16.11. GSK plc
- 16.12. Illumina Inc
- 16.13. Johnson & Johnson
- 16.14. Koninklijke Philips N.V.
- 16.15. McKesson Corporation
- 16.16. Medtronic plc
- 16.17. Merck & Co Inc
- 16.18. Moderna Inc
- 16.19. Myriad Genetics Inc
- 16.20. Pfizer Inc
- 16.21. Quest Diagnostics Incorporated
- 16.22. ResMed Inc
- 16.23. Roche Holding AG
- 16.24. Siemens Healthineers AG
- 16.25. Tata Consultancy Services Limited
- 16.26. Teladoc Health Inc
- 16.27. UnitedHealth Group Incorporated
- 16.28. Wipro Limited
